Tocilizumab Beats Steroids for Controlling Blood Vessel Inflammation in Study
WEDNESDAY, July 26, 2017 -- The drug tocilizumab performs better than steroids in treating the most common form of blood vessel inflammation known as giant cell arteritis, a new study has shown.
The phase 3 clinical trial of 251 patients confirmed...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news